Patents by Inventor Graeme Langlands

Graeme Langlands has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR
    Publication number: 20190046510
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Application
    Filed: March 8, 2018
    Publication date: February 14, 2019
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR
    Publication number: 20170326119
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Application
    Filed: December 20, 2016
    Publication date: November 16, 2017
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • Pharmaceutical salts and polymorphs of a factor Xa inhibitor
    Patent number: 9555023
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: January 31, 2017
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR
    Publication number: 20160101089
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Application
    Filed: May 18, 2015
    Publication date: April 14, 2016
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • Pharmaceutical salts and polymorphs of a factor Xa inhibitor
    Patent number: 9061019
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Grant
    Filed: February 17, 2014
    Date of Patent: June 23, 2015
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR
    Publication number: 20140288028
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Application
    Filed: February 17, 2014
    Publication date: September 25, 2014
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • Methods of using crystalline forms of a salt of a factor Xa inhibitor
    Patent number: 8557852
    Abstract: The present invention provides methods for preventing or treating a condition characterized by undesired thrombosis in a mammal using a crystalline polymorph form of a maleate salt of a compound of Formula I that has activity against mammalian factor Xa.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: October 15, 2013
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR
    Publication number: 20130064806
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Application
    Filed: September 12, 2012
    Publication date: March 14, 2013
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR
    Publication number: 20100063113
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Application
    Filed: August 28, 2009
    Publication date: March 11, 2010
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • Pharmaceutical salts and polymorphs of a factor Xa inhibitor
    Patent number: 7598276
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Grant
    Filed: November 7, 2006
    Date of Patent: October 6, 2009
    Assignee: Millenium Pharmaceuticals, Inc.
    Inventors: Craig Grant, James P. Kanter, Graeme Langlands
  • Novel pharmaceutical salts and polymorphs of a factor Xa inhibitor
    Publication number: 20070112039
    Abstract: The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.
    Type: Application
    Filed: November 7, 2006
    Publication date: May 17, 2007
    Inventors: Craig Grant, James Kanter, Graeme Langlands